170 related articles for article (PubMed ID: 21151448)
1. Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.
Yan L; Lin B; Gao L; Gao S; Liu C; Wang C; Wang Y; Zhang S; Iwamori M
Int J Mol Sci; 2010 Nov; 11(11):4441-52. PubMed ID: 21151448
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
3. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
[TBL] [Abstract][Full Text] [Related]
4. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
[TBL] [Abstract][Full Text] [Related]
5. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
6. Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs.
Mandara MT; Reginato A; Foiani G; De Luca S; Guelfi G
J Vet Intern Med; 2017 Nov; 31(6):1816-1821. PubMed ID: 28875568
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
9. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
Magee PJ; Allsopp P; Samaletdin A; Rowland IR
Eur J Nutr; 2014 Feb; 53(1):345-50. PubMed ID: 23568763
[TBL] [Abstract][Full Text] [Related]
10. [Transfection of alpha1, 2-fucosyltransferase gene increases the antigenic expression of Lewis y in ovarian cancer cell line RMG-I].
Lin B; Hao YY; Wang DD; Zhu LC; Zhang SL; Saito M; Iwamori M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):284-9. PubMed ID: 18686606
[TBL] [Abstract][Full Text] [Related]
11. An inverse relationship between KAI1 expression, invasive ability, and MMP-2 expression and activity in bladder cancer cell lines.
You J; Madigan MC; Rowe A; Sajinovic M; Russell PJ; Jackson P
Urol Oncol; 2012; 30(4):502-8. PubMed ID: 20864363
[TBL] [Abstract][Full Text] [Related]
12. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
13. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
14. Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.
Li F; Lin B; Hao Y; Li Y; Liu J; Cong J; Zhu L; Liu Q; Zhang S
Int J Mol Sci; 2010 Sep; 11(10):3748-59. PubMed ID: 21152298
[TBL] [Abstract][Full Text] [Related]
15. The expression and localization of selected matrix metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors (TIMP-2 and -3) in follicular cysts of sows.
Grzesiak M; Kaminska K; Knapczyk-Stwora K; Hrabia A
Theriogenology; 2022 Jun; 185():109-120. PubMed ID: 35395587
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
17. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
Maeta H; Ohgi S; Terada T
Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the adhesive and spreading potentials of ovarian carcinoma RMG-1 cells due to increased expression of integrin alpha5beta1 with the Lewis Y-structure on transfection of the alpha1,2-fucosyltransferase gene.
Yan LM; Lin B; Zhu LC; Hao YY; Qi Y; Wang CZ; Gao S; Liu SC; Zhang SL; Iwamori M
Biochimie; 2010 Jul; 92(7):852-7. PubMed ID: 20172014
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]